The Cooper Companies

The Cooper Companies, Inc.

Company type	Public
Industry	Medical devices
Founded	1958
Headquarters	San Ramon , United States
Area served	International
Products	Contact lenses, medical devices, fertility and genomic solutions

The Cooper Companies, Inc., known commercially as CooperCompanies, is an international medical device corporation headquartered in San Ramon, California. The enterprise comprises two primary divisions: CooperVision (CVI), specializing in the production of contact lenses, and CooperSurgical (CSI), which develops medical devices along with fertility and genomic solutions tailored for the women's healthcare sector.

History

The company was originally established in 1958 under the name Martin H. Smith Co. It was incorporated as Cooper Tinsley Laboratories Inc. in 1961 and subsequently rebranded as Cooper Laboratories Inc. in 1967. The organization entered the contact lens industry through the acquisition of the UK-based lens manufacturer GlobalVision in 1972.

By 1980, Cooper Laboratories had restructured into three divisions: CooperVision, CooperCare, and CooperBiomedical; a fourth unit, Cooper Medical Devices Corp., was introduced in 1981. In 1987, the company adopted the name The Cooper Companies and underwent another reorganization in 1990, dividing into three sectors: CooperVision, CooperSurgical, and CooperVision Pharmaceuticals (the latter was dissolved in 2003).

Currently, the company operates via two main segments: CooperVision and CooperSurgical. CooperVision provides an extensive range of disposable contact lenses available in daily, biweekly, and monthly options, catering to conditions such as astigmatism, myopia, hyperopia, and presbyopia. Meanwhile, CooperSurgical concentrates on medical devices along with fertility and genomic products designed for women's health and reproductive care markets.

Acquisitions

In 2005, CooperVision acquired Ocular Sciences Inc.

CooperSurgical broadened its offerings through multiple acquisitions: AEGEA Medical in February 2021; Safe Obstetric Systems in March 2021; and Generate Life Sciences for $1.6 billion in December 2021.

In March 2022, CooperSurgical purchased Cook Medical's reproductive health division for $875 million. Additionally, that year the company acquired EnsEyers, a producer of orthokeratology and scleral contact lenses, thereby strengthening its specialty lens portfolio.

See also

• List of S&P 400 companies